Download or read book WHO Drug Information written by and published by World Health Organization. This book was released on 2022-01-28 with total page 324 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book WHO Drug Information written by World Health Organization and published by World Health Organization. This book was released on 2024-07-02 with total page 239 pages. Available in PDF, EPUB and Kindle. Book excerpt: Overview The first issue of Volume 38, includes Consultation Documents: - fluodeoxyglucose (18F) injection (fluodeoxyglucosi (18F) solution injectabilis) ATC/DDD Classification - ATC/DDD Classification (Temporary) and ATC/DDD Classification (Final) The first issue of Volume 38, concludes with: International Nonproprietary Names (INN) Recommended List No. 91
Download or read book Canadian Journal of Medical Technology written by and published by . This book was released on 1987 with total page 692 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Thyroperoxidase and Thyroid Autoimmunity written by Pierre Carayon and published by John Libbey Eurotext. This book was released on 1990 with total page 388 pages. Available in PDF, EPUB and Kindle. Book excerpt: Text in French & English. Proceedings of the International Symposium on Thyroperoxidase and Thyroid Autoimmunity, held in Marseille (France), 28-30 June 1990.
Download or read book Bulletin of the World Health Organization written by World Health Organization and published by . This book was released on 1993 with total page 536 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Immunoenzymatic Techniques written by S. Avrameas and published by Elsevier Science & Technology. This book was released on 1983 with total page 428 pages. Available in PDF, EPUB and Kindle. Book excerpt: Aandacht voor de enzymatische-immunocytochemie met de nadruk op intracellulaire penetratie van gelabelde antilichamen en de toepassing van "double staining"-methodes of monoclonale antilichamen in normale en in diverse experimentele of pathologische omstandigheden; kwantitatieve aspecten van immuno-enzymatische technieken, zoals nieuwe technische vindingen en toepassingen op verschillende gebieden, bijvoorbeeld biologie, humane en veterinaire geneeskunde, fytopathologie en experimentele ziekten
Download or read book Annales de L Institut Pasteur written by and published by . This book was released on 1988 with total page 876 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Overview written by Canada. Agriculture Canada. Animal Pathology Division and published by . This book was released on 1986 with total page 92 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Treatment of Ovarian Cancer written by A. P. Bardos and published by Nova Publishers. This book was released on 2005 with total page 248 pages. Available in PDF, EPUB and Kindle. Book excerpt: This new volume presents the latest research on therapies for ovarian cancer. Ovarian cancer is cancer that begins in the cells that constitute the ovaries, including surface epithelial cells, germ cells, and the sex cord-stromal cells. Cancer cells that metastasize from other organ sites to the ovary (most commonly breast or colon cancers) are not then considered ovarian cancer. According to the American Cancer Society, ovarian cancer accounts for 4 percent of all cancers among women and ranks fifth as a cause of their deaths from cancer. The American Cancer Society statistics for ovarian cancer estimate that there will be 25,400 new cases and 14,300 deaths in 2003. The death rate for this disease has not changed much in the last 50 years. Unfortunately, almost 70 percent of women with the common epithelial ovarian cancer are not diagnosed until the disease is advanced in stage -- i.e., has spread to the upper abdomen (stage III) or beyond (stage IV). The 5-year survival rate for these women is only 15 to 20 percent, whereas the 5-year survival rate for stage I disease patients approaches 90 percent and for stage II disease patients approaches 70 percent. Ovarian tumors are named according to the type of cells the tumor started from and whether the tumor is benign or cancerous. The three main types of ovarian tumors are: Epithelial Tumors, Germ Cell Tumors and Stromal Tumors.
Download or read book Canada Diseases Weekly Report written by Laboratory Centre for Disease Control (Canada). Bureau of Epidemiology and published by . This book was released on 1990 with total page 276 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book PASCAL written by and published by . This book was released on 1991 with total page 678 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Binding Proteins of Steroid Hormones written by Maguelone G. Forest and published by . This book was released on 1986 with total page 678 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Revue Roumaine de M decine written by and published by . This book was released on 1989 with total page 374 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Comptes rendus de l Acad mie des sciences written by and published by . This book was released on 2000 with total page 636 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book BIOLOGIE PROSPECTIVE Comptes Rendus du 9 me Colloque de Pont Mousson written by Marie-Madeleine Galteau and published by John Libbey Eurotext. This book was released on 1997 with total page 598 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Toxines et cancer written by GOUDEY-PERRIÈRE Françoise and published by Lavoisier. This book was released on 2006-11-26 with total page 333 pages. Available in PDF, EPUB and Kindle. Book excerpt: De tout temps, l'homme a eu conscience de l'intérêt thérapeutique des toxines. Certaines toxines végétales depuis longtemps utilisées figurent encore dans la pharmacopée actuelle. Viennent s'y ajouter depuis peu des toxines microbiennes. Cependant le maniement des toxines natives ou à peine modifiées reste délicat tant est faible la marge entre les effets toxiques et l'efficacité thérapeutique. Comment, dans une perspective médicale, canaliser la puissance d'action et l'efficacité d'une toxine ? Connaître sa structure, comprendre son mécanisme d'action n'est pas suffisant : il faut aussi identifier sa cible privilégiée, autrement dit un récepteur cellulaire, faute de quoi l'entreprise apparemment chimérique d'un détournement de sa puissance et de sa spécificité reste aveugle. Ce cap est franchi, depuis un certain nombre d'années, et le développement des recherches sur les toxines axées sur la thérapeutique est devenu foisonnant. Voyez telle ou telle toxine protéique ternaire, avec ses trois domaines, de fixation sur un récepteur membranaire, de translocation qui lui permet de franchir la membrane cellulaire, et d'activité enzymatique qui va alors pouvoir s'exercer dans la cellule. Qu'on parvienne à dissocier chacun de ces trois domaines en leur conservant leurs propriétés, et des possibilités nouvelles d'utilisation thérapeutique vont s'ouvrir, presque à l'infini semble-t-il. Car chacun d'entre eux pourra être couplé à une molécule active bien ciblée, et leur efficacité sera même améliorée pour peu qu'on parvienne à conjuguer leur action. Qu'un récepteur, qu'une molécule, propres au métabolisme ou à la physiologie d'une cellule cancéreuse soient identifiés, et des toxines conjuguées à un ligand de ce récepteur, de cette molécule (ce peut être un anticorps) bloqueront les canaux ioniques ou exerceront leur effet cytolytique sur cette seule cellule, sans nuire aux cellules saines. Nous voilà dégagés de l'utopie, le contenu de cet ouvrage le prouve abondamment. Et même si la concrétisation des promesses reste délicate, le champ d'action est si vaste initialement qu'il ne saurait rester improductif : il ne l'est d'ailleurs déjà plus.
